Related references
Note: Only part of the references are listed.Antibodies to watch in 2022
Helene Kaplon et al.
MABS (2022)
Contemporary Approaches for Site-Selective Dual Functionalization of Proteins
Lujuan Xu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Innovative Bioconjugation Technology for Antibody-Drug Conjugates: Proof of Concept in a CD30-Positive Lymphoma Mouse Model
Ludovic Juen et al.
BIOCONJUGATE CHEMISTRY (2021)
Diethynyl Phosphinates for Cysteine-Selective Protein Labeling and Disulfide Rebridging
Christian E. Stieger et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Interconversion of Unexpected Thiol States Affects the Stability, Structure, and Dynamics of Antibody Engineered for Site-Specific Conjugation
Carolina T. Orozco et al.
BIOCONJUGATE CHEMISTRY (2021)
Antibody-PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
Maria Maneiro et al.
ACS CHEMICAL BIOLOGY (2020)
Expeditious Total Synthesis of Hemiasterlin through a Convergent Multicomponent Strategy and Its Use in Targeted Cancer Therapeutics
Jiraborrirak Charoenpattarapreeda et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
DiPODS: A Reagent for Site-Specific Bioconjugation via the Irreversible Rebridging of Disulfide Linkages
Elaheh Khozeimeh Sarbisheh et al.
BIOCONJUGATE CHEMISTRY (2020)
General dual functionalisation of biomacromolecules via a cysteine bridging strategy
Stephen J. Walsh et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2020)
Sulfatase-cleavable linkers for antibody-drug conjugates
Jonathan D. Bargh et al.
CHEMICAL SCIENCE (2020)
Disulfide Modified IgG1: An Investigation of Biophysical Profile and Clinically Relevant Fc Interactions
Calise Bahou et al.
BIOCONJUGATE CHEMISTRY (2019)
Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer
Jason B. White et al.
MABS (2019)
Contemporary approaches to site-selective protein modification
Emily A. Hoyt et al.
NATURE REVIEWS CHEMISTRY (2019)
A Diene-Containing Noncanonical Amino Acid Enables Dual Functionality in Proteins: Rapid Diels-Alder Reaction with Maleimide or Proximity-Based Dimerization
Andre H. St Amant et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Substrate Design Enables Heterobifunctional, Dual Click Antibody Modification via Microbial Transglutaminase
Joshua A. Walker et al.
BIOCONJUGATE CHEMISTRY (2019)
A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins
Daniel T. Cohen et al.
NATURE CHEMISTRY (2019)
A general approach for the site-selective modification of native proteins, enabling the generation of stable and functional antibody-drug conjugates
Stephen J. Walsh et al.
CHEMICAL SCIENCE (2019)
ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignancies
Francesca Zammarchi et al.
BLOOD (2018)
Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis
Samuele Cazzamalli et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Reduction-rebridging strategy for the preparation of ADPN-based antibody-drug conjugates
Oleksandr Koniev et al.
MEDCHEMCOMM (2018)
Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned
William D. Hedrich et al.
CLINICAL PHARMACOKINETICS (2018)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Development of a facile antibody-drug conjugate platform for increased stability and homogeneity
Nimish Gupta et al.
CHEMICAL SCIENCE (2017)
Enabling the controlled assembly of antibody conjugates with a loading of two modules without antibody engineering
Maximillian T. W. Lee et al.
CHEMICAL SCIENCE (2017)
π-Clamp-mediated cysteine conjugation
Chi Zhang et al.
NATURE CHEMISTRY (2016)
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Thomas B. Parsons et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Recent advances in the construction of antibody-drug conjugates
Vijay Chudasama et al.
NATURE CHEMISTRY (2016)
Processes for Constructing Homogeneous Antibody Drug Conjugates
David Y. Jackson
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2016)
Construction of homogeneous antibody-drug conjugates using site-selective protein chemistry
Padma Akkapeddi et al.
CHEMICAL SCIENCE (2016)
Site-Specific Antibody-Drug Conjugates: The Nexus of Biciorthogonal Chemistry, Protein Engineering, and Drug Development
Paresh Agarwal et al.
BIOCONJUGATE CHEMISTRY (2015)
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index
Robert P. Lyon et al.
NATURE BIOTECHNOLOGY (2015)
A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
Antoine Maruani et al.
NATURE COMMUNICATIONS (2015)
Preparation of Well-Defined Antibody-Drug Conjugates through Glycan Remodeling and Strain-Promoted Azide-Alkyne Cycloadditions
Xiuru Li et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
George Badescu et al.
BIOCONJUGATE CHEMISTRY (2014)
Statistical Modeling of the Drug Load Distribution on Trastuzumab Emtansine (Kadcyla), a Lysine-Linked Antibody Drug Conjugate
Michael T. Kim et al.
BIOCONJUGATE CHEMISTRY (2014)
Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates
Robert P. Lyon et al.
NATURE BIOTECHNOLOGY (2014)
IgG subclasses and allotypes: from structure to effector functions
Gestur Vidarsson et al.
FRONTIERS IN IMMUNOLOGY (2014)
Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
Pavel Strop et al.
CHEMISTRY & BIOLOGY (2013)
Site-Specific Protein Transannination Using N-Methylpyridinium-4-carboxaldehyde
Leah S. Witus et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Site-Specific Traceless Coupling of Potent Cytotoxic Drugs to Recombinant Antibodies for Pharmacodelivery
Giulio Casi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Peter D. Senter et al.
NATURE BIOTECHNOLOGY (2012)
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
Ben-Quan Shen et al.
NATURE BIOTECHNOLOGY (2012)
The Promise of Antibody-Drug Conjugates
Beverly A. Teicher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
Jun Y. Axup et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Physicochemical Stability of the Antibody-Drug Conjugate Trastuzumab-DM1: Changes due to Modification and Conjugation Processes
Aditya A. Wakankar et al.
BIOCONJUGATE CHEMISTRY (2010)
Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
Takuo Suzuki et al.
JOURNAL OF IMMUNOLOGY (2010)
Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides
Mark E. B. Smith et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Contribution of linker stability to the activities of anticancer immunoconjugates
Stephen C. Alley et al.
BIOCONJUGATE CHEMISTRY (2008)
Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies
Roxana M. Ionescu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Jagath R. Junutula et al.
NATURE BIOTECHNOLOGY (2008)
A broad range of Fab stabilities within a host of therapeutic IgGs
Ellen Garber et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
An engineered human IgG1 antibody with longer serum half-life
PR Hinton et al.
JOURNAL OF IMMUNOLOGY (2006)
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate
KJ Hamblett et al.
CLINICAL CANCER RESEARCH (2004)
Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design
EO Saphire et al.
SCIENCE (2001)
Share Paper
